Scopio Labs
Scopio Labs61
About
What does Scopio Labs do?
Scopio Labs is a medical technology company that develops full-field digital cell morphology platforms for hematology and pathology. Their solutions aim to enhance clinical workflows by providing high-resolution digital imaging and AI-powered analysis, assisting lab experts in the fast, early, and accurate detection and diagnosis of diseases, thereby expediting patients' access to life-saving treatments.
What is Scopio Labs's revenue?
StartupHub estimates Scopio Labs's annual revenue at $31.0M (range $19.2M to $45.8M, 66% confidence), based on comparable companies in the sector.
What is Scopio Labs's valuation?
StartupHub estimates Scopio Labs's effective valuation at $527.5M (range $312.5M to $750.0M, 16% confidence), based on comparable companies in the sector.
How much funding has Scopio Labs raised?
Scopio Labs has raised a total of $125M in funding. The most recent round on record is Series D.
Where is Scopio Labs headquartered?
Scopio Labs is headquartered in Tel Aviv, Israel.
When was Scopio Labs founded?
Scopio Labs was founded in 2014.
What industry does Scopio Labs operate in?
Scopio Labs operates in Healthcare, Diagnostics, Computational Microscopes, Medical Imaging, MedTech, HealthTech.
How many employees does Scopio Labs have?
Scopio Labs has approximately 163 people on record.
No comments yet. Be the first to share your take.